Illinois Municipal Retirement Fund boosted its holdings in Avantor, Inc. (NYSE:AVTR – Free Report) by 101.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 106,232 shares of the company’s stock after buying an additional 53,429 shares during the period. Illinois Municipal Retirement Fund’s holdings in Avantor were worth $2,238,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of AVTR. State Street Corp raised its position in shares of Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after acquiring an additional 8,206,695 shares during the last quarter. Janus Henderson Group PLC increased its holdings in Avantor by 18.2% in the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after purchasing an additional 2,719,615 shares during the last quarter. Geode Capital Management LLC lifted its stake in Avantor by 7.1% in the third quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock valued at $287,791,000 after buying an additional 739,667 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after buying an additional 5,354,678 shares during the last quarter. Finally, CCLA Investment Management grew its position in shares of Avantor by 4.5% during the 4th quarter. CCLA Investment Management now owns 5,357,703 shares of the company’s stock worth $112,940,000 after buying an additional 229,199 shares during the period. 95.08% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. Raymond James reiterated an “outperform” rating and issued a $24.00 price target (down from $26.00) on shares of Avantor in a research report on Monday, February 10th. Wells Fargo & Company reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Royal Bank of Canada lowered their price objective on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research report on Monday, February 10th. UBS Group reiterated a “neutral” rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Morgan Stanley lowered their price target on Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $25.92.
Avantor Stock Performance
Shares of Avantor stock opened at $16.50 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The firm has a market cap of $11.23 billion, a price-to-earnings ratio of 15.86, a price-to-earnings-growth ratio of 1.55 and a beta of 1.28. The stock’s 50-day moving average is $20.60 and its 200-day moving average is $22.74. Avantor, Inc. has a one year low of $16.46 and a one year high of $28.00.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the prior year, the company posted $0.22 earnings per share. Equities analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- Stock Splits, Do They Really Impact Investors?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- 5 Top Rated Dividend Stocks to Consider
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.